Evaluation of hypoglycemic potential of Cuminum cyminum and its role in modulation of cognitive function in rats with induced diabetes

Background: This study investigated the effects of Cuminum cyminum (C. cyminum) on cognitive behaviour and acetylcholinesterase (AChE) levels in diabetic rats, comparing its efficacy with Glibenclamide, Sulbutiamine, and Resveratrol. Methods: Wistar rats were randomized into 12 groups (n=10) half...

Full description

Saved in:
Bibliographic Details
Main Authors: Abhishek Kumar, Amit Shekhar, Mitali Dua, Indu Jangra, Umesh Suranagi, Ekta Arora
Format: Article
Language:English
Published: Creative Pharma Assent 2024-12-01
Series:Journal of Applied Pharmaceutical Research
Subjects:
Online Access:https://japtronline.com/index.php/joapr/article/view/549
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850100988077146112
author Abhishek Kumar
Amit Shekhar
Mitali Dua
Indu Jangra
Umesh Suranagi
Ekta Arora
author_facet Abhishek Kumar
Amit Shekhar
Mitali Dua
Indu Jangra
Umesh Suranagi
Ekta Arora
author_sort Abhishek Kumar
collection DOAJ
description Background: This study investigated the effects of Cuminum cyminum (C. cyminum) on cognitive behaviour and acetylcholinesterase (AChE) levels in diabetic rats, comparing its efficacy with Glibenclamide, Sulbutiamine, and Resveratrol. Methods: Wistar rats were randomized into 12 groups (n=10) half diabetic and half non-diabetic controls and administered C. cyminum 500 mg/kg and 1000 mg/kg, Glibenclamide (5 mg/kg), Sulbutiamine (50 mg/kg), and Resveratrol (25 mg/kg). Controls included diabetic and non-diabetic rats without treatment. Blood glucose, insulin, oxidative stress markers, and AChE levels were measured, along with behavioural parameters of learning and memory using the elevated plus maze, passive avoidance, and Morris water maze. Results: Both doses of C. cyminum significantly reduced blood glucose levels (Dose I decreased blood glucose levels from 278.5 ± 3.66 mg/dl to 136.8 ± 4.91 mg/dl while dose II decreased the blood glucose levels to 138.8 ± 3.83 mg/dl) and improved learning and memory, as evidenced by faster transfer latency (TL) and better retention in the elevated plus maze and Morris water maze. The higher dose was particularly effective in reducing brain AChE levels and improving cognitive performance in passive avoidance tests. Conclusion: Both doses of C. cyminum decreased the AChE activity induced by diabetes, improving learning and memory. The antioxidant and anti-hyperglycaemic potential may partially contribute to delaying cognitive impairment. Thus, the study suggests that C. cyminum may be beneficial in mitigating behavioural and biochemical changes associated with diabetes mellitus, offering potential as a complementary therapy to existing diabetes treatments. Elaborate studies in the future are essential to explore its antidiabetic and neuroprotective potential.
format Article
id doaj-art-538d41f3f5f24a45a0b7117c76335b24
institution DOAJ
issn 2348-0335
language English
publishDate 2024-12-01
publisher Creative Pharma Assent
record_format Article
series Journal of Applied Pharmaceutical Research
spelling doaj-art-538d41f3f5f24a45a0b7117c76335b242025-08-20T02:40:10ZengCreative Pharma AssentJournal of Applied Pharmaceutical Research2348-03352024-12-0112617018310.69857/joapr.v12i6.549550Evaluation of hypoglycemic potential of Cuminum cyminum and its role in modulation of cognitive function in rats with induced diabetesAbhishek Kumar0Amit Shekhar1Mitali Dua2Indu Jangra3Umesh SuranagiEkta Arora4Satyawadi Raja Harishchandra Hospital (SRHC), Narela, Delhi Government Health Services, Delhi- 110040, IndiaDepartment of Dermatology, Moti Lal Nehru Medical College, Prayagraj-211002, India Baba Saheb Ambedkar Hospital, Rohini, Delhi-110085, IndiaDepartment of Pharmacology, Government Institute of Medical Sciences (GIMS), Greater Noida-201310, India Department of Pharmacology, Lady Harding Medical College (LHMC), New Delhi-110001, IndiaBackground: This study investigated the effects of Cuminum cyminum (C. cyminum) on cognitive behaviour and acetylcholinesterase (AChE) levels in diabetic rats, comparing its efficacy with Glibenclamide, Sulbutiamine, and Resveratrol. Methods: Wistar rats were randomized into 12 groups (n=10) half diabetic and half non-diabetic controls and administered C. cyminum 500 mg/kg and 1000 mg/kg, Glibenclamide (5 mg/kg), Sulbutiamine (50 mg/kg), and Resveratrol (25 mg/kg). Controls included diabetic and non-diabetic rats without treatment. Blood glucose, insulin, oxidative stress markers, and AChE levels were measured, along with behavioural parameters of learning and memory using the elevated plus maze, passive avoidance, and Morris water maze. Results: Both doses of C. cyminum significantly reduced blood glucose levels (Dose I decreased blood glucose levels from 278.5 ± 3.66 mg/dl to 136.8 ± 4.91 mg/dl while dose II decreased the blood glucose levels to 138.8 ± 3.83 mg/dl) and improved learning and memory, as evidenced by faster transfer latency (TL) and better retention in the elevated plus maze and Morris water maze. The higher dose was particularly effective in reducing brain AChE levels and improving cognitive performance in passive avoidance tests. Conclusion: Both doses of C. cyminum decreased the AChE activity induced by diabetes, improving learning and memory. The antioxidant and anti-hyperglycaemic potential may partially contribute to delaying cognitive impairment. Thus, the study suggests that C. cyminum may be beneficial in mitigating behavioural and biochemical changes associated with diabetes mellitus, offering potential as a complementary therapy to existing diabetes treatments. Elaborate studies in the future are essential to explore its antidiabetic and neuroprotective potential.https://japtronline.com/index.php/joapr/article/view/549acetylcholinesterasecognitioncuminum cyminumdiabetes mellitussulbutiamineresveratrol
spellingShingle Abhishek Kumar
Amit Shekhar
Mitali Dua
Indu Jangra
Umesh Suranagi
Ekta Arora
Evaluation of hypoglycemic potential of Cuminum cyminum and its role in modulation of cognitive function in rats with induced diabetes
Journal of Applied Pharmaceutical Research
acetylcholinesterase
cognition
cuminum cyminum
diabetes mellitus
sulbutiamine
resveratrol
title Evaluation of hypoglycemic potential of Cuminum cyminum and its role in modulation of cognitive function in rats with induced diabetes
title_full Evaluation of hypoglycemic potential of Cuminum cyminum and its role in modulation of cognitive function in rats with induced diabetes
title_fullStr Evaluation of hypoglycemic potential of Cuminum cyminum and its role in modulation of cognitive function in rats with induced diabetes
title_full_unstemmed Evaluation of hypoglycemic potential of Cuminum cyminum and its role in modulation of cognitive function in rats with induced diabetes
title_short Evaluation of hypoglycemic potential of Cuminum cyminum and its role in modulation of cognitive function in rats with induced diabetes
title_sort evaluation of hypoglycemic potential of cuminum cyminum and its role in modulation of cognitive function in rats with induced diabetes
topic acetylcholinesterase
cognition
cuminum cyminum
diabetes mellitus
sulbutiamine
resveratrol
url https://japtronline.com/index.php/joapr/article/view/549
work_keys_str_mv AT abhishekkumar evaluationofhypoglycemicpotentialofcuminumcyminumanditsroleinmodulationofcognitivefunctioninratswithinduceddiabetes
AT amitshekhar evaluationofhypoglycemicpotentialofcuminumcyminumanditsroleinmodulationofcognitivefunctioninratswithinduceddiabetes
AT mitalidua evaluationofhypoglycemicpotentialofcuminumcyminumanditsroleinmodulationofcognitivefunctioninratswithinduceddiabetes
AT indujangra evaluationofhypoglycemicpotentialofcuminumcyminumanditsroleinmodulationofcognitivefunctioninratswithinduceddiabetes
AT umeshsuranagi evaluationofhypoglycemicpotentialofcuminumcyminumanditsroleinmodulationofcognitivefunctioninratswithinduceddiabetes
AT ektaarora evaluationofhypoglycemicpotentialofcuminumcyminumanditsroleinmodulationofcognitivefunctioninratswithinduceddiabetes